The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Syndax Pharmaceuticals Inc (SNDX) shows that investor sentiment remained same, with the stock’s consolidated last price to $15.42. The Syndax Pharmaceuticals Inc has recorded 15,853 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Syndax Announces Participation at Stifel Healthcare Conference.
Syndax Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $15.42 and fluctuated between $15.90 as its day high and $15.20 as its day low. The current market capitalization of Syndax Pharmaceuticals Inc is $1.07B. A total of 0.78 million shares were traded on the day, compared to an average of 1.70M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, SNDX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 27 BUYs and 22 SELLs from insiders. Insiders purchased 660,011 shares during that period but sold 548,588.
In the most recent transaction, Morrison Briggs sold 52,855 shares of SNDX for 18.27 per share on Aug 09. After the transaction, the Director now owns 17,836 company shares. In a previous transaction on Aug 02, Meury William sold 83,000 shares at 20.46 per share. SNDX shares that Director owns now total 48,000.
Among the insiders who sold shares, Morrison Briggs disposed of 52,855 shares on Jul 10 at a per-share price of $20.40. This resulted in the Director holding 17,836 shares of SNDX after the transaction. In another insider transaction, Goldan Keith A. sold 577 shares at $22.31 per share on Jun 13. Company shares held by the Chief Financial Officer now total 2,628.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for SNDX in the last 3 months, the mean price target is $35.17 with high estimates of $43.00 and low estimates of $28.00. In terms of 52-week highs and lows, SNDX has a high of $29.86 and a low of $11.22.
As of this writing, SNDX has an earnings estimate of $NASDAQ 100 per share for the current quarter. EPS was calculated based on a consensus of SNDL Inc. estimates, with a high estimate of $StoneX Group Inc. per share and a lower estimate of $Vanguard Total International Bo.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SNDX’s latest balance sheet shows that the firm has $439.94M in Cash & Short Term Investments as of fiscal 2021. There were $20.97M in debt and $20.68M in liabilities at the time. Its Book Value Per Share was $5.16, while its Total Shareholder’s Equity was $408.37M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNDX is Buy with a score of 5.00.